Monte Rosa Therapeutics

GLUE · NASDAQ

$11.36+$0.70 (+6.57%)TodayMarket closed ·
Prev close $10.66

Who owns GLUE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.6% of GLUE’s shares.

  • T. Rowe Price Associates, Inc.10.3%
  • New Enterprise Associates (NEA)7.9%
  • Dimension Management, L.P.6.7%
  • BlackRock Institutional Trust Company, N.A.6.7%
  • Next 6 largest institutions30.0%
  • All other shareholders38.4%
Top institutional holders of GLUE
HolderShares% of shares
T. Rowe Price Associates, Inc.8.72M10.32%
New Enterprise Associates (NEA)6.69M7.92%
Dimension Management, L.P.5.66M6.70%
BlackRock Institutional Trust Company, N.A.5.65M6.69%
TCG Crossover Management, LLC4.62M5.47%
Vestal Point Capital, LP4.60M5.45%
BVF Partners L.P.4.46M5.28%
Baker Bros. Advisors LP4.35M5.14%
State Street Investment Management (US)3.73M4.42%
Montanova Capital, LLC3.55M4.20%

Largest mutual fund holders

Top mutual fund holders of GLUE
HolderShares% of shares
Vanguard Total Stock Market Index Fund2.56M3.03%
T. Rowe Price New Horizons Fund2.23M2.64%
State Street SPDR S&P Biotech ETF2.23M2.64%
iShares Russell 2000 ETF1.92M2.27%
T. Rowe Price Health Sciences Fund1.82M2.16%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $2.17M (17 trades) of GLUE on the open market, with no buys.

Latest GLUE insider transactions
InsiderTypeSharesValue
Bowen MatthewSale13$137
Warmuth MarkusSale9.50K$220.22K
Champoux JenniferOption exercise4.35K—
Champoux JenniferSale4.35K$101.73K
Champoux JenniferOption exercise4.35K$17.32K
Townson SharonOption exercise6.00K—
Townson SharonSale400$9.65K
Townson SharonSale5.60K$130.20K
Townson SharonOption exercise6.00K$36.84K
Behbahani AliOther15.00K—

Short interest

Settled Sep 30, 2026

Shares short
19.69M
Days to cover
18.00
% of shares outstanding
23.30%
Average daily volume
1.09M
Change since last report
+2.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.